Home » Healthcare » Pharmaceuticals » South Korea Gastrointestinal Products Market

South Korea Gastrointestinal Products Market By Devices (Endoscopy Devices, Ablation Devices, Motility Testing Devices, Biopsy Devices, Stenting Devices); By Indications (Gastrointestinal Cancers, Gastroesophageal Reflux Disease, Irritable Bowel Syndrome, Inflammatory Bowel Disease, Other Diseases); By End-User (Hospitals, Ambulatory Surgical Centers & Independent Surgical Centers, Clinics, Other End Users) – Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032

Summary
Table Of Content

REPORT ATTRIBUTE	DETAILS
Historical Period	2019-2022
Base Year	2023
Forecast Period	2024-2032
South Korea Gastrointestinal Products Market Size 2023	USD 585.17 million
South Korea Gastrointestinal Products Market, CAGR	6.67%
South Korea Gastrointestinal Products Market Size 2032	USD 1,046.73 million

Market Overview

The South Korea Gastrointestinal Products Market is projected to grow from USD 585.17 million in 2023 to USD 1,046.73 million by 2032, registering a compound annual growth rate (CAGR) of 6.67% during the forecast period.

The South Korea gastrointestinal products market is driven by a rising prevalence of gastrointestinal disorders, fueled by changing dietary habits, increasing stress levels, and an aging population. Growing awareness about digestive health and the availability of advanced treatment options are encouraging demand for effective gastrointestinal products. The healthcare system’s emphasis on early diagnosis and treatment further supports market growth. Key trends include a shift toward over-the-counter (OTC) medications, as consumers increasingly prefer convenient, self-managed healthcare solutions. Additionally, advancements in pharmaceutical formulations, such as the development of probiotics and enzyme-based therapies, are gaining traction. The integration of innovative drug delivery technologies to enhance efficacy and patient compliance also contributes significantly to market expansion. Moreover, increased investments in research and development by key players and government initiatives to improve healthcare access are expected to sustain long-term growth in the gastrointestinal products market in South Korea.

The South Korea gastrointestinal products market demonstrates significant geographical variation, driven by disparities in healthcare infrastructure, population density, and regional healthcare awareness. Urban areas, particularly Seoul Metropolitan Region and Gyeonggi Province, dominate due to their advanced medical facilities and higher consumer purchasing power. Regions like Busan, Ulsan, and Daegu are emerging as growth hubs, benefiting from improved healthcare accessibility and increasing awareness of digestive health. The market features key players such as Olympus Corporation, Fujifilm Holdings Corporation, and Shimadzu Corporation, which are actively innovating to enhance product efficacy and expand their regional presence. Additionally, companies like Karl Storz SE & Co. KG and Stryker contribute to the competitive landscape by offering advanced diagnostic and therapeutic devices. The presence of both multinational giants and domestic firms ensures diverse product availability, catering to a wide spectrum of gastrointestinal conditions across the country.

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample

Market Insights

The South Korea gastrointestinal products market was valued at USD 585.17 million in 2023 and is expected to reach USD 1,046.73 million by 2032, growing at a CAGR of 6.67%.
Increasing prevalence of gastrointestinal disorders such as GERD, IBS, and IBD is driving the market demand.
Rising awareness of digestive health and a shift toward preventive care are fueling the market’s growth.
Over-the-counter (OTC) products and probiotics are witnessing high demand due to their accessibility and perceived health benefits.
Key players in the market include Olympus Corporation, Fujifilm Holdings, Shimadzu Corporation, and Karl Storz, which are focused on innovation and expanding their product portfolios.
High costs associated with advanced treatments and stringent regulatory frameworks pose challenges for market growth.
The Seoul Metropolitan and Gyeonggi regions dominate the market, with growing opportunities in Busan and Ulsan.

Market Drivers

Rising Prevalence of Gastrointestinal Disorders

The increasing incidence of gastrointestinal disorders, such as irritable bowel syndrome (IBS), gastroesophageal reflux disease (GERD), and inflammatory bowel disease (IBD), is a major driver of the South Korea gastrointestinal products market. These conditions are attributed to changing dietary habits, sedentary lifestyles, and heightened stress levels in the population. For instance, a study by the Korean National Health Insurance Service reported that the incidence rates of ulcerative colitis, Crohn’s disease, and esophageal reflux significantly increased during the COVID-19 pandemic. Additionally, the growing aging population in South Korea, which is more prone to digestive health issues, is contributing to the rising demand for effective treatments. This demographic shift is expected to sustain market growth over the coming years as healthcare providers prioritize gastrointestinal care.

Growing Awareness of Digestive Health

Consumers in South Korea are becoming increasingly aware of the importance of digestive health and the benefits of timely treatment for gastrointestinal conditions. This awareness is driving demand for both prescription and over-the-counter (OTC) gastrointestinal products. Public health campaigns and educational initiatives by healthcare organizations and pharmaceutical companies are also playing a pivotal role in promoting digestive health. For instance, the Korea National Health and Nutrition Examination Survey (KNHANES) has been instrumental in raising public awareness about digestive health and encouraging proactive health management. As individuals seek proactive measures to maintain their well-being, the market for gastrointestinal products is witnessing substantial growth.

Advancements in Pharmaceutical Formulations

Innovations in pharmaceutical formulations are enhancing the effectiveness and safety profiles of gastrointestinal products. The introduction of probiotics, enzyme-based therapies, and targeted drug delivery systems has revolutionized treatment options, offering improved efficacy and patient compliance. Furthermore, the development of novel therapeutics, such as biologics and personalized medicine, is expanding the range of available solutions for complex gastrointestinal conditions. These advancements are not only meeting the unmet needs of patients but are also driving growth in the market.

Supportive Government and Healthcare Policies

Government initiatives aimed at improving healthcare access and affordability are supporting the growth of the South Korea gastrointestinal products market. Subsidies for essential medications and investment in healthcare infrastructure ensure that a wider population has access to effective gastrointestinal treatments. For instance, the Ministry of Health and Welfare’s 2024 Action Plan includes measures to enhance healthcare access and support the development of innovative medical products. Additionally, favorable regulatory frameworks for the approval of new products encourage pharmaceutical companies to introduce innovative solutions, thereby fostering market expansion.

Market Trends

Shift Toward Over-the-Counter (OTC) Products

The South Korea gastrointestinal products market is witnessing a growing preference for over-the-counter (OTC) medications. Consumers are increasingly leaning toward self-medication and readily accessible solutions to manage common gastrointestinal conditions such as acid reflux, indigestion, and bloating. This trend is driven by greater awareness of digestive health, busy lifestyles, and the convenience of purchasing OTC products without a prescription. For instance, the production value of OTC drug products in South Korea reached around 3.6 trillion South Korean won in 2022, reflecting the increasing consumer preference for these accessible solutions. Pharmaceutical companies are responding by expanding their OTC portfolios with improved formulations and targeted marketing strategies to appeal to health-conscious consumers.

Increasing Adoption of Probiotics and Functional Products

Probiotics and functional gastrointestinal products are gaining significant traction in South Korea. As consumers prioritize preventive healthcare and natural remedies, demand for probiotics, prebiotics, and enzyme-based supplements has surged. These products are widely perceived as safe and effective in promoting gut health, boosting immunity, and addressing mild digestive issues. For instance, the Ministry of Food and Drug Safety (MFDS) reported that the probiotics market in South Korea grew from 217.4 billion won in 2017 to 525.6 billion won in 2020. The popularity of such functional products is further amplified by the growing availability of innovative formulations, including chewable tablets, drinks, and sachets, which enhance user convenience and adherence.

Advancements in Drug Delivery Technologies

The integration of advanced drug delivery systems into gastrointestinal products is a notable trend driving market innovation. Technologies such as controlled-release formulations and targeted delivery mechanisms are enhancing the efficacy and safety profiles of treatments for chronic gastrointestinal conditions. These advancements not only improve therapeutic outcomes but also increase patient compliance by reducing dosing frequency and minimizing side effects. As pharmaceutical companies invest heavily in research and development, these technological innovations are expected to shape the future of the market.

Growing Focus on Personalized Medicine

Personalized medicine is emerging as a transformative trend in the South Korea gastrointestinal products market. Leveraging genetic profiling and advanced diagnostics, healthcare providers can offer tailored treatment regimens for complex gastrointestinal disorders. This approach enhances treatment efficacy and minimizes adverse effects, aligning with the broader trend of precision healthcare. As technology and infrastructure for personalized medicine continue to evolve, its adoption in gastrointestinal care is expected to accelerate, offering significant opportunities for market growth.

Market Challenges Analysis

High Costs of Advanced Treatments

One of the significant challenges facing the South Korea gastrointestinal products market is the high cost of advanced treatments. Innovative therapeutics, such as biologics and personalized medicine, often come with premium pricing, making them less accessible to a considerable segment of the population. For instance, the cost of advanced gastrointestinal treatments at leading hospitals like Samsung Medical Center and Asan Medical Center can be prohibitively high for many patients. While government subsidies and insurance programs mitigate these costs for some patients, many still face financial barriers in accessing these advanced solutions. This challenge is particularly pronounced for chronic and severe conditions requiring long-term treatment, where affordability becomes a critical factor. Pharmaceutical companies and healthcare policymakers must address these pricing concerns to ensure equitable access and sustained market growth.

Stringent Regulatory Requirements

The regulatory landscape for gastrointestinal products in South Korea is highly stringent, posing challenges for market players. Companies must navigate rigorous approval processes to ensure the safety and efficacy of new products, which often lead to longer development timelines and increased costs. For instance, the Ministry of Food and Drug Safety (MFDS) has established stringent guidelines for the approval of new medical products, which can extend the time required for market entry. Additionally, post-market surveillance and compliance with changing regulations add to operational complexities. These hurdles can deter smaller companies and startups from entering the market and limit the pace of innovation. Collaboration between regulatory authorities and the pharmaceutical industry is essential to streamline processes while maintaining high safety standards, thereby fostering a more conducive environment for market expansion.

Market Opportunities

Growing Demand for Preventive Healthcare Solutions

The rising emphasis on preventive healthcare presents significant opportunities in the South Korea gastrointestinal products market. Increasing awareness about the importance of maintaining digestive health is driving demand for preventive solutions, including probiotics, prebiotics, and dietary supplements. Consumers are proactively seeking products that support gut health and enhance overall well-being, creating a lucrative market for functional gastrointestinal products. Pharmaceutical companies and nutraceutical brands can capitalize on this trend by developing innovative, easy-to-consume formulations tailored to consumer preferences. Moreover, strategic marketing campaigns highlighting the benefits of preventive care can further boost adoption rates and expand market reach.

Expanding Role of Digital Healthcare

The growing integration of digital healthcare technologies offers immense potential for the gastrointestinal products market in South Korea. Telemedicine platforms and health apps are making it easier for patients to access consultations, monitor symptoms, and receive personalized treatment recommendations for gastrointestinal disorders. Additionally, advancements in digital diagnostics, such as smart sensors and AI-powered analysis tools, are enabling earlier and more accurate identification of digestive health issues. Companies that leverage these technologies to offer innovative, patient-centric solutions stand to gain a competitive edge. Collaborations between pharmaceutical companies, technology firms, and healthcare providers can further accelerate the adoption of digital healthcare, unlocking new growth avenues in the gastrointestinal products sector.

Market Segmentation Analysis:

By Devices:

The South Korea gastrointestinal products market is segmented by devices, including endoscopy devices, ablation devices, motility testing devices, biopsy devices, and stenting devices. Endoscopy devices dominate this segment due to their widespread use in diagnosing and treating various gastrointestinal conditions such as ulcers, cancers, and inflammatory bowel diseases. Advancements in endoscopic technology, including high-definition imaging and minimally invasive procedures, further bolster their adoption. Motility testing devices are gaining traction as they play a crucial role in diagnosing functional gastrointestinal disorders like irritable bowel syndrome (IBS). Similarly, ablation and stenting devices are increasingly utilized in treating complex conditions, such as gastrointestinal cancers and obstructions, offering effective solutions to enhance patient outcomes.

By Indications:

Based on indications, the market includes gastrointestinal cancers, gastroesophageal reflux disease (GERD), irritable bowel syndrome (IBS), inflammatory bowel disease (IBD), and other diseases. Gastrointestinal cancers represent a significant share due to the rising prevalence and the critical need for early detection and effective treatment. GERD and IBS are also key contributors to market growth, driven by lifestyle changes and stress-related disorders. Additionally, inflammatory bowel diseases, such as Crohn’s disease and ulcerative colitis, are fueling demand for advanced therapies. The “other diseases” category covers less common but impactful conditions, creating niche opportunities for targeted solutions. This diverse segmentation ensures sustained growth across multiple therapeutic areas.

Segments:

Based on Devices:

Endoscopy Devices
Ablation Devices
Motility Testing Devices
Biopsy Devices
Stenting Devices

Based on Indications:

Gastrointestinal Cancers
Gastroesophageal Reflux Disease
Irritable Bowel Syndrome
Inflammatory Bowel Disease
Other Diseases

Based on End-User:

Hospitals
Ambulatory Surgical Centers & Independent Surgical Centers
Clinics
Other End Users

Based on the Geography:

Seoul Metropolitan Region
Gyeonggi Province
Busan and Ulsan Regions
Daegu Region

Regional Analysis

Seoul Metropolitan Region

The Seoul Metropolitan Region holds the largest market share in the South Korea gastrointestinal products market, accounting for approximately 35% of the total market in 2023. This dominance is attributed to the region’s advanced healthcare infrastructure, higher disposable income levels, and concentration of leading hospitals and research institutions. Seoul’s dense population and access to specialized healthcare services have resulted in a higher prevalence of gastrointestinal diagnoses and treatments. Furthermore, the region serves as a hub for pharmaceutical companies and healthcare providers, fostering innovation and availability of cutting-edge gastrointestinal products. The proactive approach to preventive healthcare among Seoul’s population further supports the robust demand for both prescription and over-the-counter (OTC) gastrointestinal products.

Gyeonggi Province

Gyeonggi Province accounts for around 28% of the South Korea gastrointestinal products market, making it the second-largest contributor. The region’s substantial population and growing urbanization drive demand for healthcare products, including gastrointestinal treatments. Gyeonggi Province benefits from its proximity to Seoul, enabling easy access to advanced healthcare services and a steady supply of pharmaceutical products. Increased awareness of digestive health and a rise in the prevalence of lifestyle-related gastrointestinal conditions, such as GERD and irritable bowel syndrome (IBS), are key growth drivers in this region. The growing presence of regional hospitals and clinics enhances healthcare accessibility, supporting continued market expansion.

Busan and Ulsan Regions

The Busan and Ulsan regions collectively account for approximately 20% of the South Korea gastrointestinal products market. These industrial hubs are experiencing rising demand for gastrointestinal treatments due to an aging population and increased stress-related digestive issues among working professionals. Efforts to improve healthcare infrastructure, including the establishment of specialized medical centers, are fostering market growth. The regions’ growing focus on medical tourism, particularly for gastrointestinal treatments, offers additional opportunities for pharmaceutical companies. Busan’s role as a major port city also ensures efficient distribution of gastrointestinal products, further enhancing its market potential.

Daegu Region

The Daegu region contributes about 17% to the South Korea gastrointestinal products market, reflecting its growing healthcare investments and increasing prevalence of digestive disorders. Daegu’s strategic focus on medical research and the development of advanced treatment facilities have improved patient access to gastrointestinal care. Rising awareness campaigns and public health initiatives have further bolstered the demand for preventive and therapeutic solutions in this region. Additionally, Daegu’s emerging role as a regional healthcare hub creates opportunities for companies to expand their reach and cater to a broader patient base.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Customize Now

Key Player Analysis

Machida Endoscope Co.
Olympus Corporation
Fujifilm Holdings Corporation
Shimadzu Corporation
Karl Storz SE & Co. KG
Stryker
Smith & Nephew
Karl Storz
Hoya
Company 10
Company 11
Company 12
Company 13
Company 14

Competitive Analysis

The competitive landscape of South Korea’s gastrointestinal products market is marked by the presence of several leading players that are focused on innovation, technological advancements, and strategic partnerships. Key players include Olympus Corporation, Fujifilm Holdings Corporation, Shimadzu Corporation, Karl Storz SE & Co. KG, Stryker, and Smith & Nephew, among others. Leading companies in the market focus on continuous innovation, with an emphasis on enhancing the quality and efficacy of diagnostic and therapeutic devices. They prioritize research and development to offer cutting-edge solutions such as advanced endoscopy systems, biopsy devices, motility testing equipment, and ablation tools. For instance, Olympus Corporation has been at the forefront of developing high-definition endoscopy systems that significantly improve diagnostic accuracy. Competition is further intensified by the introduction of minimally invasive technologies, which are driving the demand for more effective and less disruptive treatments. Companies are investing in next-generation technologies, including high-definition imaging, robotic-assisted systems, and AI-powered diagnostic tools, to improve patient outcomes and provide healthcare professionals with more accurate diagnostic capabilities. Strategic partnerships, mergers, and acquisitions are key strategies adopted by companies to expand their product portfolios and increase their market share. Additionally, firms are focusing on enhancing their distribution networks to reach a broader customer base, particularly in regional markets. The competitive environment is expected to evolve as these players continue to innovate and adapt to the growing demand for gastrointestinal care in South Korea.

Recent Developments

In April 2023, Boston Scientific announced the launch of the EXALT Model B Single-use Bronchoscope, which expands its single-use endoscopy portfolio. This device is designed for diagnostic and therapeutic bronchoscopy procedures and offers high-resolution imaging and precise control.
In March 2023, Polifarma Spa expanded its gastrointestinal portfolio through a long-term distribution agreement with Devintec Pharma Sagl, a Lugano-based company known for pioneering substance-based medical devices and the Gelsectan brand.
In April 2023, Italian pharmaceutical innovator Azienda Farmaceutica Italiana partnered with TannerLAC, Inc. to distribute Hepilor, a medical device designed to protect the digestive system mucosa, throughout Latin America.
In May 2022, Dr. Reddy’s Laboratories Ltd. announced a partnership with South Korea’s HK inno.N Corporation to supply and commercialize HK inno.N’s patented novel molecule, Tegoprazan, for treating gastrointestinal diseases in India and six key emerging markets.
In March 2022, AbbVie Inc. received U.S. FDA approval for its novel drug, RINVOQ (upadacitinib), for the treatment of moderately to severely active ulcerative colitis.

Market Concentration & Characteristics

The market concentration of South Korea’s gastrointestinal products sector is moderate, with a mix of multinational corporations and domestic companies leading the space. While the market is dominated by a few large players, particularly those offering advanced diagnostic and therapeutic devices like endoscopy and biopsy tools, there is room for smaller firms to innovate in niche segments such as over-the-counter (OTC) products and dietary supplements. The competitive dynamics are influenced by the rapid pace of technological advancement, especially in minimally invasive procedures and AI-driven diagnostics. Large companies leverage economies of scale, advanced R&D capabilities, and strong distribution networks to maintain their market share. The characteristics of the South Korea gastrointestinal products market reflect a growing demand for precision, efficiency, and patient-centered care. The shift towards minimally invasive procedures, coupled with increased awareness of gastrointestinal health, has transformed the product landscape. Moreover, the market is marked by a trend towards preventive healthcare, with consumers increasingly seeking products that support digestive well-being. Companies are also focusing on providing cost-effective solutions, as healthcare affordability remains a key concern. Regulatory frameworks are stringent, ensuring that only safe and effective products enter the market, further shaping the competitive environment. Overall, the market is evolving toward more advanced, patient-focused solutions.

Report Coverage

The research report offers an in-depth analysis based on Devices, Indications, End-User and Geography. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.

Future Outlook

The South Korea gastrointestinal products market is expected to continue its growth trajectory, driven by increasing prevalence of digestive disorders.
Demand for preventive healthcare solutions, such as probiotics and dietary supplements, will likely rise due to changing consumer preferences.
Technological advancements, including AI-driven diagnostics and robotic-assisted surgeries, are expected to play a key role in market expansion.
Companies are likely to invest in expanding their product portfolios to include more advanced and minimally invasive devices.
There will be increased focus on personalized medicine and targeted therapies for gastrointestinal conditions.
Telemedicine and digital healthcare solutions will offer new opportunities for market growth, particularly in rural areas.
The competitive landscape is likely to witness partnerships and collaborations to enhance product offerings.
Regulatory standards will remain stringent, emphasizing safety and efficacy of new products.
Expansion into emerging markets, such as Busan and Ulsan, is expected to create growth opportunities for regional players.
The market will continue to evolve towards more patient-centric and technologically advanced healthcare solutions.

CHAPTER NO. 1 : INTRODUCTION 20

1.1.1. Report Description 20

Purpose of the Report 20

USP & Key Offerings 20

1.1.2. Key Benefits for Stakeholders 20

1.1.3. Target Audience 21

1.1.4. Report Scope 21

CHAPTER NO. 2 : EXECUTIVE SUMMARY 22

2.1. GASTROINTESTINAL PRODUCTS Market Snapshot 22

2.1.1. South Korea GASTROINTESTINAL PRODUCTS Market, 2018 – 2032 (USD Million) 23

CHAPTER NO. 3 : GEOPOLITICAL CRISIS IMPACT ANALYSIS 24

3.1. Russia-Ukraine and Israel-Palestine War Impacts 24

CHAPTER NO. 4 : GASTROINTESTINAL PRODUCTS MARKET – INDUSTRY ANALYSIS 25

4.1. Introduction 25

4.2. Market Drivers 26

4.2.1. GI Disorders on a Rise 26

4.2.2. New and innovative technologies driving the market 27

4.3. Market Restraints 28

4.3.1. Stringent Regulations 28

4.4. Market Opportunities 29

4.4.1. Market Opportunity Analysis 29

4.5. Porter’s Five Forces Analysis 30

4.6. Value Chain Analysis 31

4.7. Buying Criteria 32

CHAPTER NO. 5 : IMPORT EXPORT ANALYSIS 33

5.1. Import Analysis by South Korea 33

5.1.1. South Korea GASTROINTESTINAL PRODUCTS Market Import Volume/Revenue, By South Korea, 2018 – 2023 33

5.2. Export Analysis by South Korea 34

5.2.1. South Korea GASTROINTESTINAL PRODUCTS Market Export Volume/Revenue, By South Korea, 2018 – 2023 34

CHAPTER NO. 6 : DEMAND SUPPLY ANALYSIS 35

6.1. Demand Analysis by South Korea 35

6.1.1. South Korea GASTROINTESTINAL PRODUCTS Market Demand Volume/Revenue, By South Korea, 2018 – 2023 35

6.2. Supply Analysis by South Korea 36

6.2.1. South Korea GASTROINTESTINAL PRODUCTS Market Supply Volume/Revenue, By South Korea, 2018 – 2023 36

CHAPTER NO. 7 : PRODUCTION ANALYSIS 37

7.1. Production Analysis by South Korea 37

7.1.1. South Korea GASTROINTESTINAL PRODUCTS Market Production Volume/Revenue, By South Korea, 2018 – 2023 37

CHAPTER NO. 8 : PRICE ANALYSIS 38

8.1. Price Analysis by Devices 38

8.1.1. South Korea GASTROINTESTINAL PRODUCTS Market Price, By Devices, 2018 – 2023 38

8.1.2. South Korea Devices Market Price, By Devices, 2018 – 2023 38

CHAPTER NO. 9 : RAW MATERIALS ANALYSIS 39

9.1. Key Raw Materials and Suppliers 39

9.2. Key Raw Materials Price Trend 39

CHAPTER NO. 10 : MANUFACTURING COST ANALYSIS 40

10.1. Manufacturing Cost Analysis 40

10.2. Manufacturing Process 40

CHAPTER NO. 11 : ANALYSIS COMPETITIVE LANDSCAPE 41

11.1. Company Market Share Analysis – 2023 41

11.1.1. South Korea GASTROINTESTINAL PRODUCTS Market: Company Market Share, by Volume, 2023 41

11.1.2. South Korea GASTROINTESTINAL PRODUCTS Market: Company Market Share, by Revenue, 2023 42

11.1.3. South Korea GASTROINTESTINAL PRODUCTS Market: Top 6 Company Market Share, by Revenue, 2023 42

11.1.4. South Korea GASTROINTESTINAL PRODUCTS Market: Top 3 Company Market Share, by Revenue, 2023 43

11.2. South Korea GASTROINTESTINAL PRODUCTS Market Company Volume Market Share, 2023 44

11.3. South Korea GASTROINTESTINAL PRODUCTS Market Company Revenue Market Share, 2023 45

11.4. Company Assessment Metrics, 2023 46

11.4.1. Stars 46

11.4.2. Emerging Leaders 46

11.4.3. Pervasive Players 46

11.4.4. Participants 46

11.5. Start-ups /SMEs Assessment Metrics, 2023 46

11.5.1. Progressive Companies 46

11.5.2. Responsive Companies 46

11.5.3. Dynamic Companies 46

11.5.4. Starting Blocks 46

11.6. Strategic Developments 47

11.6.1. Acquisitions & Mergers 47

New Product Launch 47

South Korea Expansion 47

11.7. Key Players Product Matrix 48

CHAPTER NO. 12 : PESTEL & ADJACENT MARKET ANALYSIS 49

12.1. PESTEL 49

12.1.1. Political Factors 49

12.1.2. Economic Factors 49

12.1.3. Social Factors 49

12.1.4. Technological Factors 49

12.1.5. Environmental Factors 49

12.1.6. Legal Factors 49

12.2. Adjacent Market Analysis 49

CHAPTER NO. 13 : GASTROINTESTINAL PRODUCTS MARKET – BY DEVICES SEGMENT ANALYSIS 50

13.1. GASTROINTESTINAL PRODUCTS Market Overview, by Devices Segment 50

13.1.1. GASTROINTESTINAL PRODUCTS Market Revenue Share, By Devices, 2023 & 2032 51

13.1.2. GASTROINTESTINAL PRODUCTS Market Attractiveness Analysis, By Devices 52

13.1.3. Incremental Revenue Growth Opportunity, by Devices, 2024 – 2032 52

13.1.4. GASTROINTESTINAL PRODUCTS Market Revenue, By Devices, 2018, 2023, 2027 & 2032 53

13.2. Endoscopy Devices 54

13.3. Ablation Devices 55

13.4. Motility Testing Devices 56

13.5. Biospy Devices 57

13.6. Stenting Devices 58

CHAPTER NO. 14 : GASTROINTESTINAL PRODUCTS MARKET – BY INDICATIONS SEGMENT ANALYSIS 59

14.1. GASTROINTESTINAL PRODUCTS Market Overview, by Indications Segment 59

14.1.1. GASTROINTESTINAL PRODUCTS Market Revenue Share, By Indications, 2023 & 2032 60

14.1.2. GASTROINTESTINAL PRODUCTS Market Attractiveness Analysis, By Indications 61

14.1.3. Incremental Revenue Growth Opportunity, by Indications, 2024 – 2032 61

14.1.4. GASTROINTESTINAL PRODUCTS Market Revenue, By Indications, 2018, 2023, 2027 & 2032 62

14.2. Gastrointestinal Cancers 63

14.3. Gastroesophageal Reflux Disease 64

14.4. Irritable Bowl Syndrome 65

14.5. Inflammatory Bowel Disease 66

14.6. Other Disease 67

CHAPTER NO. 15 : GASTROINTESTINAL PRODUCTS MARKET – BY END-USER SEGMENT ANALYSIS 68

15.1. GASTROINTESTINAL PRODUCTS Market Overview, by End-user Segment 68

15.1.1. GASTROINTESTINAL PRODUCTS Market Revenue Share, By End-user, 2023 & 2032 69

15.1.2. GASTROINTESTINAL PRODUCTS Market Attractiveness Analysis, By End-user 70

15.1.3. Incremental Revenue Growth Opportunity, by End-user, 2024 – 2032 70

15.1.4. GASTROINTESTINAL PRODUCTS Market Revenue, By End-user, 2018, 2023, 2027 & 2032 71

15.2. Hospital 72

15.3. Ambulatory Surgical Center & Independent Surgical Center 73

15.4. Clinics 74

15.5. Other End Users 75

CHAPTER NO. 16 : COMPANY PROFILES 76

16.1. Machida Endoscope Co 76

16.1.1. Company Overview 76

16.1.2. Product Portfolio 76

16.1.3. Swot Analysis 76

16.1.4. Business Strategy 77

16.1.5. Financial Overview 77

16.2. Olympus Corporation 78

16.3. Fujifilm Holdings Corporation 78

16.4. Shimadzu Corporation 78

16.5. Karl Storz SE & Co. KG 78

16.6. Stryker 78

16.7. Smith & Nephew 78

16.8. Karl Storz 78

16.9. Hoya 78

16.10. Company 10 78

16.11. Company 11 78

16.12. Company 12 78

16.13. Company 13 78

16.14. Company 14 78

List of Figures

FIG NO. 1. South Korea GASTROINTESTINAL PRODUCTS Market Revenue, 2018 – 2032 (USD Million) 22

FIG NO. 2. Porter’s Five Forces Analysis for South Korea GASTROINTESTINAL PRODUCTS Market 29

FIG NO. 3. Value Chain Analysis for South Korea GASTROINTESTINAL PRODUCTS Market 30

FIG NO. 4. South Korea GASTROINTESTINAL PRODUCTS Market Import Volume/Revenue, By South Korea, 2018 – 2023 32

FIG NO. 5. South Korea GASTROINTESTINAL PRODUCTS Market Export Volume/Revenue, By South Korea, 2018 – 2023 33

FIG NO. 6. South Korea GASTROINTESTINAL PRODUCTS Market Demand Volume/Revenue, By South Korea, 2018 – 2023 34

FIG NO. 7. South Korea GASTROINTESTINAL PRODUCTS Market Supply Volume/Revenue, By South Korea, 2018 – 2023 35

FIG NO. 8. South Korea GASTROINTESTINAL PRODUCTS Market Production Volume/Revenue, By South Korea, 2018 – 2023 36

FIG NO. 9. South Korea GASTROINTESTINAL PRODUCTS Market Price, By Devices, 2018 – 2023 37

FIG NO. 10. Raw Materials Price Trend Analysis, 2018 – 2023 38

FIG NO. 11. Manufacturing Cost Analysis 39

FIG NO. 12. Manufacturing Process 39

FIG NO. 13. Company Share Analysis, 2023 40

FIG NO. 14. Company Share Analysis, 2023 41

FIG NO. 15. Company Share Analysis, 2023 41

FIG NO. 16. Company Share Analysis, 2023 42

FIG NO. 17. GASTROINTESTINAL PRODUCTS Market – Company Volume Market Share, 2023 43

FIG NO. 18. GASTROINTESTINAL PRODUCTS Market – Company Revenue Market Share, 2023 44

FIG NO. 19. GASTROINTESTINAL PRODUCTS Market Revenue Share, By Devices, 2023 & 2032 50

FIG NO. 20. Market Attractiveness Analysis, By Devices 51

FIG NO. 21. Incremental Revenue Growth Opportunity by Devices, 2024 – 2032 51

FIG NO. 22. GASTROINTESTINAL PRODUCTS Market Revenue, By Devices, 2018, 2023, 2027 & 2032 52

FIG NO. 23. South Korea GASTROINTESTINAL PRODUCTS Market for Endoscopy Devices, Revenue (USD Million) 2018 – 2032 53

FIG NO. 24. South Korea GASTROINTESTINAL PRODUCTS Market for Ablation Devices, Revenue (USD Million) 2018 – 2032 54

FIG NO. 25. South Korea GASTROINTESTINAL PRODUCTS Market for Motility Testing Devices, Revenue (USD Million) 2018 – 2032 55

FIG NO. 26. South Korea GASTROINTESTINAL PRODUCTS Market for Biospy Devices, Revenue (USD Million) 2018 – 2032 56

FIG NO. 27. South Korea GASTROINTESTINAL PRODUCTS Market for Stenting Devices, Revenue (USD Million) 2018 – 2032 57

FIG NO. 28. GASTROINTESTINAL PRODUCTS Market Revenue Share, By Indications, 2023 & 2032 59

FIG NO. 29. Market Attractiveness Analysis, By Indications 60

FIG NO. 30. Incremental Revenue Growth Opportunity by Indications, 2024 – 2032 60

FIG NO. 31. GASTROINTESTINAL PRODUCTS Market Revenue, By Indications, 2018, 2023, 2027 & 2032 61

FIG NO. 32. South Korea GASTROINTESTINAL PRODUCTS Market for Gastrointestinal Cancers, Revenue (USD Million) 2018 – 2032 62

FIG NO. 33. South Korea GASTROINTESTINAL PRODUCTS Market for Gastroesophageal Reflux Disease, Revenue (USD Million) 2018 – 2032 63

FIG NO. 34. South Korea GASTROINTESTINAL PRODUCTS Market for Irritable Bowl Syndrome, Revenue (USD Million) 2018 – 2032 64

FIG NO. 35. South Korea GASTROINTESTINAL PRODUCTS Market for Inflammatory Bowel Disease, Revenue (USD Million) 2018 – 2032 65

FIG NO. 36. South Korea GASTROINTESTINAL PRODUCTS Market for Other Disease, Revenue (USD Million) 2018 – 2032 66

FIG NO. 37. GASTROINTESTINAL PRODUCTS Market Revenue Share, By End-user, 2023 & 2032 68

FIG NO. 38. Market Attractiveness Analysis, By End-user 69

FIG NO. 39. Incremental Revenue Growth Opportunity by End-user, 2024 – 2032 69

FIG NO. 40. GASTROINTESTINAL PRODUCTS Market Revenue, By End-user, 2018, 2023, 2027 & 2032 70

FIG NO. 41. South Korea GASTROINTESTINAL PRODUCTS Market for Hospital, Revenue (USD Million) 2018 – 2032 71

FIG NO. 42. South Korea GASTROINTESTINAL PRODUCTS Market for Ambulatory Surgical Center & Independent Surgical Center, Revenue (USD Million) 2018 – 2032 72

FIG NO. 43. South Korea GASTROINTESTINAL PRODUCTS Market for Clinics, Revenue (USD Million) 2018 – 2032 73

FIG NO. 44. South Korea GASTROINTESTINAL PRODUCTS Market for Other End Users, Revenue (USD Million) 2018 – 2032 74

FIG NO. 45. South Korea GASTROINTESTINAL PRODUCTS Market for End-user 5, Revenue (USD Million) 2018 – 2032 75

FIG NO. 46. GASTROINTESTINAL PRODUCTS Market Revenue Share, By Technology, 2023 & 2032 77

FIG NO. 47. Market Attractiveness Analysis, By Technology 78

FIG NO. 48. Incremental Revenue Growth Opportunity by Technology, 2024 – 2032 78

FIG NO. 49. GASTROINTESTINAL PRODUCTS Market Revenue, By Technology, 2018, 2023, 2027 & 2032 79

FIG NO. 50. South Korea GASTROINTESTINAL PRODUCTS Market for Technology 1, Revenue (USD Million) 2018 – 2032 80

FIG NO. 51. South Korea GASTROINTESTINAL PRODUCTS Market for Technology 2, Revenue (USD Million) 2018 – 2032 81

FIG NO. 52. South Korea GASTROINTESTINAL PRODUCTS Market for Technology 3, Revenue (USD Million) 2018 – 2032 82

FIG NO. 53. GASTROINTESTINAL PRODUCTS Market Revenue Share, By Distribution Channel, 2023 & 2032 84

FIG NO. 54. Market Attractiveness Analysis, By Distribution Channel 85

FIG NO. 55. Incremental Revenue Growth Opportunity by Distribution Channel, 2024 – 2032 85

FIG NO. 56. GASTROINTESTINAL PRODUCTS Market Revenue, By Distribution Channel, 2018, 2023, 2027 & 2032 86

FIG NO. 57. South Korea GASTROINTESTINAL PRODUCTS Market for Distribution Channel 1, Revenue (USD Million) 2018 – 2032 87

FIG NO. 58. South Korea GASTROINTESTINAL PRODUCTS Market for Distribution Channel 2, Revenue (USD Million) 2018 – 2032 88

FIG NO. 59. South Korea GASTROINTESTINAL PRODUCTS Market for Distribution Channel 3, Revenue (USD Million) 2018 – 2032 89

FIG NO. 60. South Korea GASTROINTESTINAL PRODUCTS Market for Distribution Channel 4, Revenue (USD Million) 2018 – 2032 90

FIG NO. 61. South Korea GASTROINTESTINAL PRODUCTS Market for Distribution Channel 5, Revenue (USD Million) 2018 – 2032 91

FIG NO. 62. Research Methodology – Detailed View 100

FIG NO. 63. Research Methodology 101

List of Tables

TABLE NO. 1. : South Korea GASTROINTESTINAL PRODUCTS Market: Snapshot 18

TABLE NO. 2. : Drivers for the GASTROINTESTINAL PRODUCTS Market: Impact Analysis 22

TABLE NO. 3. : Restraints for the GASTROINTESTINAL PRODUCTS Market: Impact Analysis 24

TABLE NO. 4. : South Korea GASTROINTESTINAL PRODUCTS Market Revenue, By Devices, 2018 – 2023 34

TABLE NO. 5. : Key Raw Materials & Suppliers 35

TABLE NO. 6. : South Korea GASTROINTESTINAL PRODUCTS Market Revenue, By Devices, 2018 – 2023 (USD Million) 89

TABLE NO. 7. : South Korea GASTROINTESTINAL PRODUCTS Market Revenue, By Devices, 2024 – 2032 (USD Million) 89

TABLE NO. 8. : South Korea GASTROINTESTINAL PRODUCTS Market Revenue, By Indications, 2018 – 2023 (USD Million) 90

TABLE NO. 9. : South Korea GASTROINTESTINAL PRODUCTS Market Revenue, By Indications, 2024 – 2032 (USD Million) 90

TABLE NO. 10. : South Korea GASTROINTESTINAL PRODUCTS Market Revenue, By End-user, 2018 – 2023 (USD Million) 91

TABLE NO. 11. : South Korea GASTROINTESTINAL PRODUCTS Market Revenue, By End-user, 2024 – 2032 (USD Million) 91

TABLE NO. 12. : South Korea GASTROINTESTINAL PRODUCTS Market Revenue, By Technology, 2018 – 2023 (USD Million) 92

TABLE NO. 13. : South Korea GASTROINTESTINAL PRODUCTS Market Revenue, By Technology, 2024 – 2032 (USD Million) 92

TABLE NO. 14. : South Korea GASTROINTESTINAL PRODUCTS Market Revenue, By Distribution Channel, 2018 – 2023 (USD Million) 93

TABLE NO. 15. : South Korea GASTROINTESTINAL PRODUCTS Market Revenue, By Distribution Channel, 2024 – 2032 (USD Million) 93

Frequently Asked Questions

What is the current size of the South Korea Gastrointestinal Products market?

The South Korea gastrointestinal products market is valued at USD 585.17 million in 2023 and is projected to grow to USD 1,046.73 million by 2032, registering a compound annual growth rate (CAGR) of 6.67%.

What factors are driving the growth of the South Korea Gastrointestinal Products market?

The market is driven by the rising prevalence of gastrointestinal disorders such as GERD, IBS, and IBD, fueled by changing dietary habits, increased stress levels, and an aging population. Additional growth factors include heightened awareness of digestive health, advancements in pharmaceutical formulations, the shift toward over-the-counter (OTC) products, and government initiatives supporting healthcare access and innovation.

What are the key segments within the South Korea Gastrointestinal Products market?

Key segments include:
• By Devices: Endoscopy Devices, Ablation Devices, Motility Testing Devices, Biopsy Devices, and Stenting Devices.
• By Indications: Gastrointestinal Cancers, Gastroesophageal Reflux Disease (GERD), Irritable Bowel Syndrome (IBS), Inflammatory Bowel Disease (IBD), and Other Diseases.
• By End-User: Hospitals, Ambulatory Surgical Centers & Independent Surgical Centers, Clinics, and Other End Users.
• By Geography: Seoul Metropolitan Region, Gyeonggi Province, Busan and Ulsan Regions, and Daegu Region.

What are some challenges faced by the South Korea Gastrointestinal Products market?

Challenges include the high costs associated with advanced treatments such as biologics and personalized medicine, which limit affordability for some patients. Stringent regulatory requirements also pose barriers, as approval processes for new products are lengthy and complex, increasing costs and delaying market entry for innovative solutions.

Who are the major players in the South Korea Gastrointestinal Products market?

Key players include Olympus Corporation, Fujifilm Holdings Corporation, Shimadzu Corporation, Karl Storz SE & Co. KG, Stryker, and Smith & Nephew. These companies focus on innovation, offering advanced diagnostic and therapeutic devices, and expanding their product portfolios to meet the growing demand for gastrointestinal healthcare solutions.

Purchase Options

Single User

$2699

Multi User

$3699

Custom Report

$5699

Request Free Sample

Have a question?

Don’t settle for less – trust Mitul to help you find the best solution.

Call: +91 6232 49 3207

EMAIL MITUL

Report delivery within 24 to 48 hours

– Other Info –

–What people say?-

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –